Antimicrobial Resistance Surveillance Market Size was valued at USD 6.1 Billion in 2022. The Antimicrobial Resistance Surveillance market industry is projected to grow from USD 6.5 Billion in 2023 to USD 10.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.90% during the forecast period (2024 - 2032). Increased prevalence of antimicrobial-resistant pathogens worldwide is the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for antimicrobial resistance surveillance is being driven by the rising incidence of antimicrobial resistance. As antimicrobial-resistant pathogens become increasingly prevalent worldwide, there is a growing need for effective surveillance strategies to monitor and combat this public health threat. Surveillance programs play a crucial role in tracking the emergence and spread of resistant strains, identifying trends, and informing public health interventions and treatment guidelines. Healthcare facilities, laboratories, and public health agencies are investing in surveillance technologies and services to enhance their capacity to detect and respond to antimicrobial resistance. Additionally, the escalation of AMR-related morbidity, mortality, and healthcare costs further underscores the urgency of implementing robust surveillance systems, driving market growth as stakeholders prioritize efforts to mitigate the impact of antimicrobial resistance on global health.
Advancements in diagnostic technologies are driving the Antimicrobial Resistance Surveillance Market by revolutionizing the detection and monitoring of antimicrobial-resistant pathogens. Next-generation sequencing, PCR-based assays, and rapid susceptibility testing methods enable faster, more accurate, and comprehensive identification of resistant strains. These technologies offer increased sensitivity and specificity, allowing for the detection of resistance mechanisms and the prediction of antimicrobial susceptibility profiles. Additionally, advancements in bioinformatics facilitate the analysis and interpretation of complex genomic data, enhancing surveillance capabilities. Healthcare facilities and laboratories are increasingly adopting these innovative diagnostic tools to improve their antimicrobial resistance surveillance efforts. With the growing importance of timely and effective interventions to combat antimicrobial resistance, the demand for advanced diagnostic technologies continues to drive market growth, enabling stakeholders to better understand and respond to the evolving landscape of antimicrobial resistance.
Awareness and education initiatives are playing a pivotal role in driving the Antimicrobial Resistance Surveillance Market. Increased awareness among healthcare professionals, policymakers, and the general public about the threats posed by antimicrobial resistance (AMR) has led to greater recognition of the importance of surveillance in combating this global health challenge. Educational campaigns and initiatives aimed at promoting responsible antimicrobial use, infection control practices, and the appropriate use of surveillance technologies have heightened demand for surveillance solutions. Moreover, as stakeholders become more informed about the impact of AMR on patient outcomes, healthcare systems, and society as a whole, there is a greater willingness to invest in surveillance strategies. Collaborative efforts between governments, healthcare organizations, and advocacy groups further amplify the impact of awareness and education initiatives, driving market growth in the Antimicrobial Resistance Surveillance sector.
For instance, Element Materials Technology, a prominent company specializing in Testing, Inspection, and Certification (TIC) services across various products, has recently acquired JMI Laboratories. Through this acquisition, Element now provides microbiology and molecular testing services, aiding in the development of novel antimicrobials and supporting clinical trials. This strategic move is part of Element's broader initiative to expand its footprint in the global life sciences sector.
The Antimicrobial Resistance Surveillance Market segmentation, based on Solution, includes Kits, System, Surveillance Software, and Service. In 2023, the Kits segment dominated the market, accounting for 30% of market revenue due to their convenience, versatility, and reliability. These solutions offer ready-to-use assays and reagents for the rapid detection and characterization of antimicrobial-resistant pathogens. They streamline the testing process, require minimal technical expertise, and provide accurate results, making them widely adopted by healthcare facilities and laboratories. Additionally, kits solutions often come with standardized protocols and quality controls, ensuring consistent performance and facilitating large-scale surveillance efforts, thereby solidifying their dominance in the market.
System solutions are experiencing the highest compound annual growth rate (CAGR) in the Antimicrobial Resistance Surveillance Market due to their comprehensive and integrated approach to surveillance. These solutions offer end-to-end platforms that automate data collection, analysis, and reporting, streamlining surveillance workflows and enhancing efficiency. Moreover, system solutions often incorporate advanced technologies such as artificial intelligence and machine learning, enabling real-time monitoring and predictive analytics. As healthcare facilities seek more sophisticated and scalable surveillance solutions, system solutions are increasingly preferred, driving their rapid growth in the market.
The Antimicrobial Resistance Surveillance Market segmentation, based on Application, includes Clinical Diagnostics and Public Health Surveillance. In 2023, the Clinical Diagnostics category generated the most income due to its crucial role in patient care and treatment decisions. These applications involve the detection and characterization of antimicrobial-resistant pathogens in clinical settings, guiding clinicians in selecting appropriate antimicrobial therapies. With the rising incidence of resistant infections and the growing emphasis on precision medicine, clinical diagnostics applications are in high demand. Their ability to provide timely and actionable information for patient management contributes to their dominance in the market.
The Public Health Surveillance Application is experiencing the highest compound annual growth rate (CAGR) in the Antimicrobial Resistance Surveillance Market due to several key factors. Public health surveillance plays a critical role in monitoring and controlling the spread of antimicrobial-resistant pathogens on a population level. With increasing global concern about antimicrobial resistance, governments, and public health agencies are investing in surveillance programs to track outbreaks, inform policy decisions, and implement interventions, driving the growth of this application segment in the market.
The Antimicrobial Resistance Surveillance Market segmentation, based on End User, includes Hospitals, Clinics, Academic and Research Institutes. In 2023, the hospitals category generated the most income due to several key factors. Hospitals are at the forefront of patient care and are, therefore, deeply invested in monitoring and managing antimicrobial resistance. They rely on surveillance systems to track resistant pathogens within their facilities, guide treatment decisions, and implement infection control measures. Additionally, hospitals have the infrastructure and resources to conduct comprehensive surveillance activities, contributing to their dominance in the market.
Clinics end users are experiencing the highest Compound Annual Growth Rate (CAGR) in the Antimicrobial Resistance Surveillance Market due to several factors. First, clinics are increasingly recognizing the critical importance of surveillance in managing antimicrobial resistance. Second, advancements in technology have made surveillance tools more accessible and user-friendly for clinics. Third, there's a growing awareness among healthcare professionals about the need for proactive monitoring to prevent outbreaks and optimize treatment strategies. These factors collectively contribute to the rapid growth of clinics as end users in this market.
Figure 1: Antimicrobial Resistance Surveillance Market, by End User, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific, and the Rest of the World. North America dominates the Antimicrobial Resistance Surveillance Market primarily due to robust healthcare infrastructure, extensive research and development initiatives, and stringent regulatory frameworks promoting antimicrobial stewardship. Moreover, increasing incidences of antimicrobial-resistant infections, coupled with proactive government initiatives and high healthcare expenditure, further drive market growth. Additionally, the presence of key market players and collaborations between research institutes and pharmaceutical companies foster innovation and technological advancements, consolidating North America's position as the leading region in the antimicrobial resistance surveillance market.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.
Figure 2: Antimicrobial Resistance Surveillance Market Share By Region 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Antimicrobial Resistance Surveillance market accounts for the second-largest market share due to the low extensive research infrastructure. Europe holds the second-largest market share in the Antimicrobial Resistance Surveillance Market due to several factors. The region boasts a sophisticated healthcare system, extensive research infrastructure, and significant government initiatives addressing antimicrobial resistance. Additionally, stringent regulations regarding antibiotics use and robust surveillance programs contribute to market growth. Furthermore, increasing awareness among healthcare professionals and the general population regarding the importance of antimicrobial stewardship drives the adoption of surveillance technologies. These factors collectively position Europe as a key player in the antimicrobial resistance surveillance market. Further, the German Antimicrobial Resistance Surveillance market held the largest market share, and the UK Antimicrobial Resistance Surveillance market was the fastest growing market in the European region.
The Asia-Pacific Antimicrobial Resistance Surveillance Market is expected to grow at the fastest CAGR from 2024 to 2032. The Asia Pacific region is experiencing the highest Compound Annual Growth Rate (CAGR) in the Antimicrobial Resistance Surveillance Market due to several factors. Rapid population growth, urbanization, and increasing healthcare expenditure drive the demand for surveillance solutions. Moreover, rising incidences of antimicrobial-resistant infections, coupled with improving healthcare infrastructure and government initiatives to combat antimicrobial resistance, further fuel market growth. Additionally, growing awareness among healthcare providers and investment in research and development contribute to the region's accelerated growth in antimicrobial resistance surveillance. Moreover, China’s Antimicrobial Resistance Surveillance market held the largest market share, and the Indian Antimicrobial Resistance Surveillance market was the fastest growing market in the Asia-Pacific region.
Antimicrobial Resistance Surveillance Key Market Players & Competitive Insights
Leading players in the Antimicrobial Resistance Surveillance Market are focusing on strategic initiatives to maintain their competitive edge. This includes mergers and acquisitions to expand their product portfolios and geographic presence. Additionally, investments in research and market developments are aimed at developing innovative surveillance technologies to address emerging challenges in antimicrobial resistance. Furthermore, collaborations with healthcare institutions and government agencies help develop comprehensive surveillance solutions. Overall, these players are striving to offer advanced and comprehensive antimicrobial resistance surveillance solutions to meet the evolving needs of the market.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Antimicrobial Resistance Surveillance industry to benefit clients and increase the market sector. In recent years, the Antimicrobial Resistance Surveillance industry has offered some of the most significant advantages to hospitals. Major players in the Antimicrobial Resistance Surveillance market, including Thermo Fisher Scientific Inc., BioMérieux SA, Becton, Dickinson and Company, Danaher Corporation, Roche Diagnostics International Ltd., Siemens Healthineers, Bruker Corporation, Agilent Technologies, Inc., Abbott Laboratories, Cepheid Inc. and Others, are attempting to increase market demand by investing in research and development operations.
Thermo Fisher Scientific Inc. is a leading player in the Antimicrobial Resistance Surveillance Market, offering a comprehensive range of solutions for surveillance and detection of antimicrobial resistance. The company provides innovative molecular diagnostics tools, including PCR assays and sequencing platforms, for rapid and accurate identification of resistant pathogens. Thermo Fisher's broad portfolio also encompasses antimicrobial susceptibility testing systems, automated laboratory workflows, and informatics solutions for data management and analysis. With a global presence and a strong focus on research and development, Thermo Fisher Scientific continues to drive advancements in antimicrobial resistance surveillance, enabling healthcare providers and public health agencies to effectively monitor and combat the spread of resistant pathogens.
BioMérieux SA is a key player in the Antimicrobial Resistance Surveillance Market, renowned for its expertise in microbiology diagnostics. The company offers a wide array of solutions for antimicrobial resistance surveillance, including automated microbial identification systems, antimicrobial susceptibility testing platforms, and molecular diagnostics assays. BioMérieux's products enable rapid and accurate detection of resistant pathogens, empowering healthcare professionals to make informed treatment decisions and implement effective infection control measures. With a strong focus on innovation and collaboration with healthcare institutions and research organizations, BioMérieux continues to advance the field of antimicrobial resistance surveillance. Their commitment to improving patient outcomes and reducing the global burden of antimicrobial resistance solidifies their position as a leader in the market.
Key Companies in the Antimicrobial Resistance Surveillance market include
Antimicrobial Resistance Surveillance Industry Developments
June 2022: DiaSorin S.p.A., a laboratory diagnostics provider with expertise in immunodiagnostics and molecular diagnostics, introduced the LIAISON MeMed BV test. This test assists physicians in distinguishing between viral and bacterial infections. Its introduction addresses a critical need in combating the escalating global challenge of antimicrobial resistance (AMR).
May 2023: The UK government declared an allocation of up to GBP 39 million (equivalent to USD 50.11 million) in funding for antimicrobial resistance (AMR) research via the Global AMR Innovation Fund (GAMRIF).
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 6.1 Billion |
| Market Size 2023 | USD 6.5 Billion |
| Market Size 2032 | USD 10.2 Billion |
| Compound Annual Growth Rate (CAGR) | 5.90% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Solution, Application, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea |
| Key Companies Profiled | Thermo Fisher Scientific Inc., BioMérieux SA, Becton, Dickinson and Company, Danaher Corporation, Roche Diagnostics International Ltd., Siemens Healthineers, Bruker Corporation, Agilent Technologies, Inc., Abbott Laboratories, Cepheid Inc. and Others |
| Key Market Opportunities | · Integrated Surveillance Solutions and Point-of-Care Testing |
| Key Market Dynamics | · Rising Incidence of Antimicrobial Resistance and Advancements in Diagnostic Technologies |
Frequently Asked Questions (FAQ) :
The Antimicrobial Resistance Surveillance Market size was valued at USD 6.5 Billion in 2023.
The global market is projected to grow at a CAGR of 5.90% during the forecast period, 2024-2032.
North America had the largest share in the global market.
The key players in the market are Thermo Fisher Scientific Inc., BioMérieux SA, Becton, Dickinson and Company, Danaher Corporation, Roche Diagnostics International Ltd., Siemens Healthineers, Bruker Corporation, Agilent Technologies, Inc., Abbott Laboratories, Cepheid Inc. and Others.
The Kits category dominated the market in 2023.
Clinical Diagnostics had the largest share in the global market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
